Back to all MindMaze Therapeutics Holding SA press releases
MindMaze Therapeutics Holding SA
- OTCQB:MMTZF
- SIX:MMTX
MindMaze Announces RLF-OD032 Rights Sale and Planned Organisational Simplification
Published
At a glance
- Company
- MindMaze Therapeutics Holding SA
- Listings
- OTCQB:MMTZF, SIX:MMTX
- Announcement type
- Merger or acquisition
- Published
- Source announcement
- eqs-news.com
| Measure | Figure |
|---|---|
| Upfront cash consideration | USD 3 million |
Figures are quoted from this announcement and selected automatically.
FAQSIR Generated from this announcement View original release below for safe harbor and regulatory notices
Announcement Summary
MindMaze Therapeutics Holding SA (SIX: MMTX) announced the sale of rights to RLF-OD032 and an organizational simplification initiative.
- The sale covers U.S. and Canadian rights to RLF-OD032, a phenylketonuria program, for USD 3 million upfront and future-net-sales royalties.
- The Company executed term sheets covering substantially all remaining non-neurology legacy operations acquired through its business combination with Relief Therapeutics.
- The Company expects the transactions to simplify the organization, focus operations, and reduce its cost base by approximately one-third.
- Subject to definitive agreements, the Company expects the organizational simplification initiative to be substantially completed during the third quarter of 2026.
Proceeds from the RLF-OD032 sale, together with the recently announced CHF 8 million financing, will support neurology priorities, including commercial expansion and broader patient access.
Investor FAQs
Source announcement
- Company
- MindMaze Therapeutics Holding SA
- Title
- MindMaze Therapeutics Announces Non-Core Asset Sale and Organizational Simplification
- Published
- Source site
- eqs-news.com
Read the source announcement on eqs-news.com
FAQSIR's summary and investor FAQs are generated by AI from the text of this announcement alone, without information from other sources.
Figures, forecasts and other claims are the announcement's, not FAQSIR's. FAQSIR does not independently verify them.
Read the original press release
Full text as published, unedited.